A Study of Biomarkers of Mild Traumatic BRAIN Injury

CompletedOBSERVATIONAL
Enrollment

1,501

Participants

Timeline

Start Date

August 10, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

September 28, 2021

Conditions
Mild Traumatic Brain Injury
Interventions
OTHER

2 x 5 mL blood sample

2 x 5 mL blood sample to determine the performance of the automated VIDAS BTI platform in assessing serum concentrations of GFAP and UCH-L1 to rule out the need for a CT-scan after mTBI.

Trial Locations (16)

Unknown

Centre Hospitalier Annecy Genevois, Annecy

CHU Bordeaux, Bordeaux

CHU Dijon, Dijon

CHU Grenoble Alpes, Grenoble

Hopital Edouard HERRIOT - HCL, Lyon

Hopital Lyon Sud HCL, Lyon

CHU Montpellier, Montpellier

CHU Nantes, Nantes

CHU Poitiers, Poitiers

CHU Toulouse, Toulouse

CHU Tours, Tours

Hôpital Nord Ouest de Villefranche sur Saône, Villefranche-sur-Saône

Hospital de La Princesa, Madrid

Hospital del Tajo, Madrid

Hospital Gregorio Maranon, Madrid

Hospital Universitario de 12 Octubre, Madrid

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT04032509 - A Study of Biomarkers of Mild Traumatic BRAIN Injury | Biotech Hunter | Biotech Hunter